Editorially independent content, supported with advertising
10.22.26
The debates at AAO Retina Subspecialty Day have a reputation for examining unresolved issues. Where did the debate on whether wet AMD tolerates fluid land? Avni Finn, MD, joined the show to recap her side of the wet AMD fluid debate—and shared what the opposite side had to argue, too. How well does she buy her own argument?
And Darius Moshfeghi, MD, joins the show to share findings from the SOL-1 study examining OTX-TKI (Ocular Therapeutix) for wet AMD. What did the researchers find? And how did the study authors leverage AI to simulate real-world treatment activity? Join us on this episode to find out.
Editorially independent content supported by Genentech
10.22.26
AAO '26: Fluid Debates in Wet AMD + OTX-TKI for Wet AMDAvni Finn, MD; and Darius Moshfeghi, MD
Editorially independent content supported by Genentech
08.27.26
ASRS '26: ArMaDa/GARDian Results and Real-World YAG Complication IncidenceJay Chhablani, MD; and Jordan Deaner, MD
Editorially Independent Content Supported by Genentech
08.05.26
ASRS '26: SOL-1 and TRUCKEE at 4.5 YearsDilsher Dhoot, MD; and Carl Danzig, MD
Editorially independent content, supported by Genentech.
06.18.26
ARVO '26: TKIs for Wet AMD and How We Got to the AI Era of ResearchAkshay Thomas, MD; Aaron Lee, MD, MSCI; and Cecelia Lee, MD, MS
Editorially independent content, supported by Genentech.
06.04.26
ARVO '26: DME Delphi Study and RHONE-XBaruch Kuppermann, MD, PhD; and Murtaza Adam, MD
Editorially independent content, supported by Genentech.
11.13.25
AAO '25: GLP-1s and AMD, and Parity in Retina CareAleksandra Rachitskaya, MD; and Julia Haller, MD
Editorially independent content, supported by Genentech.
11.10.25
Late-Breaking Talks at AAO '25: Phase 3 for Uveitic Macular Edema and GATHER2 OLERahul Khurana, MD; and Arshad Khanani, MD, MA
Editorially independent content, supported by Genentech.
11.06.25
AAO '25: Dry AMD Pipeline and Oral Treatment for Stargardt DiseasePeter Kaiser, MD; and Michel Michaelides, MD
Editorially independent content, supported by Genentech.
10.23.25
Late-Breaking Talks at AAO '25: Gene Therapy for RP and NPDRAllen Ho, MD; and Charles Wykoff, MD, PhD
Editorially independent content, supported by Genentech.
09.04.25
ASRS '25: ReCLAIM-2 and Continuous Glucose Monitoring in NPDRDavid Lally, MD; and Ehsan Rahimy, MD
Editorially independent content, supported by Genentech
Show More